423 related articles for article (PubMed ID: 9194537)
1. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
[TBL] [Abstract][Full Text] [Related]
2. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
Schrör K; Latta G; Darius H; Klaus W; Ziegler R
Klin Wochenschr; 1985 Jan; 63(1):16-9. PubMed ID: 3838352
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation as an acute effect of cigarette smoking.
Kimura S; Nishinaga M; Ozawa T; Shimada K
Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287
[TBL] [Abstract][Full Text] [Related]
5. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
Tohgi H; Takahashi H; Chiba K; Tamura K
Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
7. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
8. [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients].
Yu Z; Chen KJ
Zhong Xi Yi Jie He Za Zhi; 1987 Jan; 7(1):8-11, 3. PubMed ID: 2954711
[No Abstract] [Full Text] [Related]
9. The molecular markers of hemostatic activation on coronary artery disease.
Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
[TBL] [Abstract][Full Text] [Related]
10. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
Legnani C; Frascaro M; Guazzaloca G; Ludovici S; Cesarano G; Coccheri S
Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
[TBL] [Abstract][Full Text] [Related]
11. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
12. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
[TBL] [Abstract][Full Text] [Related]
13. Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets.
Palés J; Palacios-Araus L; López A; Gual A
Biochim Biophys Acta; 1991 May; 1064(2):169-74. PubMed ID: 1645196
[TBL] [Abstract][Full Text] [Related]
14. Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease.
Hallén J; Atar D; Serebruany V
Am J Ther; 2014; 21(2):91-8. PubMed ID: 19770797
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
[TBL] [Abstract][Full Text] [Related]
16. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
[TBL] [Abstract][Full Text] [Related]
18. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
20. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]